Get the Stockscreener App
58.74
1.29%
0.75
After Hours:
58.74
Apogee Therapeutics Inc stock is traded at $58.74, with a volume of 420.71K.
It is up +1.29% in the last 24 hours and up +14.79% over the past month.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
See More
Previous Close:
$57.99
Open:
$57.82
24h Volume:
420.71K
Relative Volume:
0.97
Market Cap:
$3.33B
Revenue:
-
Net Income/Loss:
$-118.49M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-110.57M
1W Performance:
+1.80%
1M Performance:
+14.79%
6M Performance:
-11.60%
1Y Performance:
+175.77%
1-Day Range:
$57.43
$60.09
1-Week Range:
$55.92
$60.35
52-Week Range:
$14.19
$72.29
Apogee Therapeutics Inc Stock (APGE) Company Profile
Name
Apogee Therapeutics Inc
Sector
Industry
Phone
650-394-5230
Address
221 CRESCENT ST., WALTHAM
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-23 | Initiated | BTIG Research | Buy |
| Aug-08-23 | Initiated | Guggenheim | Buy |
| Aug-08-23 | Initiated | Jefferies | Buy |
| Aug-08-23 | Initiated | Stifel | Buy |
| Aug-08-23 | Initiated | TD Cowen | Outperform |
| Aug-08-23 | Initiated | Wedbush | Outperform |
View All
Apogee Therapeutics Inc Stock (APGE) Latest News
Perceptive Advisors LLC Grows Position in Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat
Driehaus Capital Management LLC Buys 54,107 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat
Renaissance Technologies LLC Has $6.15 Million Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat
Point72 DIFC Ltd Takes $660,000 Position in Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat
Apogee Therapeutics (NASDAQ:APGE) Shares Gap Down to $59.92 - Defense World
Apogee Therapeutics (NASDAQ:APGE) Shares Gap Down to $59.92 - MarketBeat
Affinity Asset Advisors LLC Raises Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat
Long Term Trading Analysis for (APGE) - Stock Traders Daily
Is Apogee Therapeutics Inc. (APGE) worth investing in despite its undervalued state? - US Post News
Integral Health Asset Management LLC Has $3.15 Million Stock Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat
History of violence at Atlanta apartment complex where man, woman found shot to death: Records - 11Alive.com WXIA
HighVista Strategies LLC Has $3.11 Million Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
Atlanta Community Shaken by Double Homicide on Hollywood Road NW, Police Investigate Shooting - Hoodline
APGE’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
2 people dead after shooting at northwest Atlanta apartment complex - WSB Atlanta
2 shot to death at northwest Atlanta apartment complex, police say - Atlanta News First
Man and woman found shot to death in northwest Atlanta, police say - 11Alive.com WXIA
Woman killed in Powellhurst-Gilbert shooting remembered as ‘good person’ with ‘radiant smile’ - Yahoo! Voices
Apogee Therapeutics (NASDAQ:APGE) Stock Price Up 3.3% - MarketBeat
The Future of Apogee Therapeutics Inc.: Analyzing APGE - The InvestChronicle
Eagle Plains Partner Apogee Completes Airborne Geophysical Survey at Pine Channel Gold and Shasko Bay Uranium Projects, Northern Saskatchewan - Yahoo Finance
The Road to IPO - Yahoo Finance
FMR LLC Acquires New Stake in Bicara Therapeutics Inc - Yahoo Finance
Apogee Enterprises Announces Date for Fiscal 2025 Second Quarter Financial Results - Yahoo Finance
Apogee Introduces Symphony Studio Series - Sonic State
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Victory Capital Management Inc. Has $6.15 Million Position in Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat
Taking a Closer Look At Apogee Therapeutics Inc. (APGE) Following Its Recent Trade - Knox Daily
When the Price of (APGE) Talks, People Listen - Stock Traders Daily
First Turn Management LLC Sells 61,476 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat
TD Asset Management Inc Sells 53,200 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) - MarketBeat
TD Asset Management Inc Reduces Stock Position in Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year? - Yahoo Finance
Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit - GlobeNewswire
Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit - Yahoo Finance
Analysts review Apogee Therapeutics Inc.’s rating - Knox Daily
Apogee Therapeutics (NASDAQ:APGE) Trading Up 5.2% - MarketBeat
Apogee Therapeutics Inc. (APGE) shows promising results - US Post News
Daily Market Movement: Apogee Therapeutics Inc. (APGE) Sees a 0.55 Increase, Closing at 47.51 - The Dwinnex
Apogee Therapeutics, Inc. Appoints Jeff S. Hartness as Chief Commercial Officer - Marketscreener.com
Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer - GlobeNewswire
Apogee Therapeutics names new Chief Commercial Officer - Investing.com
Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer - EIN News
Michael Thomas Henderson Sells 40,000 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) Stock - Defense World
Apogee Therapeutics CEO sells over $1.9 million in stock By Investing.com - Investing.com Australia
Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE) - Yahoo Finance
Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE) By GuruFocus - Investing.com Canada
Apogee Therapeutics CMO sells over $316k in company stock - Investing.com India
Carl Dambkowski Sells 6,665 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) Stock - MarketBeat
Apogee Therapeutics CEO sells over $1.9 million in stock - Investing.com India
Apogee Therapeutics CMO sells over $316k in company stock - Investing.com
Apogee Therapeutics Inc Stock (APGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):